When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LGND - Ligand's Revenue Soars in Q1 Thanks to Gilead's COVID Drug
Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals (NASDAQ: LGND) stock skyrocketed earlier this year. However, the short squeeze that fueled those massive gains is now over . That means that Ligand probably needs a more conventional catalyst to go on another run.
The company announced its first-quarter results after the market closed on Monday. Don't expect those results to provide the catalyst investors wanted. The biotech stock fell more than 6% in after-hours trading. Here are the highlights from Ligand's Q1 update.